Microsoft (MSFT) rises Thursday evening on Q4 earnings beat >>> READ MORE

The 3 Best Biotech ETF Investments

Get direct exposure to the biotech sector with these funds

      View All  

iShares Nasdaq Biotech ETF (IBB)

biotech etf ibbTotal Assets Under Management: $4 billion
Expense Ratio: 0.48%

One biotech ETF worth your consideration is the iShares Nasdaq Biotech ETF (IBB). This fund has been around for more than a decade and has ample assets under management of $4 billion.

IBB is a pretty pure play on biotech stocks. Nearly 80% of the 120 holdings of iShares Nasdaq Biotech ETF are straight biotech stocks — and big ones at that. The average market cap for companies this biotech ETF? $13 billion.

Top holdings of the iShares Nasdaq Biotech ETF include big biotech stocks like Biogen (BIIB) and Celgene (CELG) with nearly 9% slices each. Behind them are Gilead Sciences (GILD) at 8.5% and Amgen (AMGN) at 8.1%.

This biotech ETF gives you big-name exposure to the sector at a reasonable expense ratio of 0.48%, or $48 annually for every $10,000 invested.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC